Neumora Therapeutics OverviewNeumora Therapeutics Other Income Expense Net
Other Income/Expense Net for NMRA.
Quarterly Other Income/Expense
-$564000.00
↓ 118.5% YoY
As of Mar 31, 2026
Annual Other Income/Expense (TTM)
$745000.00
↓ 95.5% YoY
Trailing 12 months ending Mar 31, 2026